Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Puma Biotechnology, Inc. (PBYI) Posts Q2 Loss of $1.05/Share
August 11, 2014 4:51 PM EDTPuma Biotechnology, Inc. (NYSE: PBYI) reported Q2 EPS of ($1.05), $0.39 worse than the analyst estimate of ($0.66).
For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.
... More